SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
xyr
Lv1
2
90 积分
2024-08-14 加入
最近求助
最近应助
互助留言
Primary Large B-cell Lymphomas of Immune-Privileged Sites
2小时前
待确认
Primary Large B-cell Lymphomas of Immune-Privileged Sites
2小时前
已关闭
Primary Large B-cell Lymphomas of Immune-Privileged Sites
2小时前
已关闭
Genetic Characteristics and Outcomes By Mutation Status in a Phase 3 Study of CPX-351 Versus 7+3 in Older Adults with Newly Diagnosed, High-Risk/Secondary Acute Myeloid Leukemia (AML)
10天前
已完结
Genetic Characteristics and Outcomes By Mutation Status in a Phase 3 Study of CPX-351 Versus 7+3 in Older Adults with Newly Diagnosed, High-Risk/Secondary Acute Myeloid Leukemia (AML)
10天前
已关闭
Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study
10天前
已完结
2024 Update: Advances in the risk stratification and management of large B‐cell lymphoma
11天前
已完结
Real‐world comparative effectiveness of venetoclax‐obinutuzumab versus Bruton tyrosine kinase inhibitors for frontline chronic lymphocytic leukaemia
16天前
已完结
The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions
24天前
已完结
The genomic basis of childhood T-lineage acute lymphoblastic leukaemia
1个月前
已完结
没有进行任何应助
感谢
1个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论